Podcast Summary: Med Spa Success Strategies – Episode on GLP-1 Legal Updates, Non-Competes & Compliance

Title: GLP-1 Legal Updates, Non-Competes & Compliance
Host: Ricky Shockley
Guest: Courtney Walker
Release Date: February 28, 2025

Introduction

In this insightful episode of Med Spa Success Strategies, host Ricky Shockley welcomes Courtney Walker, a seasoned expert in regulatory compliance and strategic legal guidance for med spa and aesthetics practices. With a formidable background that includes advising governmental bodies and overseeing significant mergers and acquisitions, Courtney brings a wealth of knowledge to help med spa owners navigate complex legal landscapes.

GLP-1 Legal Updates

Overview of Recent FDA Changes

At the onset ([00:02]), Ricky sets the stage by introducing the timely topic of GLP-1 medications, specifically semaglutide and tirzepatide. Courtney Walker delves into the latest FDA updates, revealing that both tirzepatide and semaglutide have been removed from the FDA’s shortage list as of October and recently, respectively ([01:03]). This removal imposes new restrictions on compounding pharmacies, limiting their ability to manufacture these medications until their patents expire.

Implications for Compounding Pharmacies and Med Spas

Courtney explains the dynamics of demand versus supply, noting that increased demand for these medications often leads to shortages, which in turn creates opportunities for compounding pharmacies to produce investigational formulations ([01:03]). However, with the recent FDA decisions, compounding pharmacies must adhere strictly to registered standards or cease production of these medications ([01:03]).

Operational Challenges and Compliance

Med spa owners face new operational challenges, such as proving the medical necessity for using compounded versions of GLP-1 drugs. Courtney emphasizes the importance of conducting medical evaluations and lab tests to justify the use of compounded medications over patented ones ([06:17]). She advises med spa practitioners to review their malpractice insurance policies to ensure coverage when prescribing GLP-1s ([06:26]).

Non-Competes and FTC Rulings

FTC's Nationwide Ban on Non-Competes

Courtney addresses the Federal Trade Commission’s (FTC) recent ruling banning non-compete clauses nationwide, highlighting its constitutional challenges ([40:46]). The ruling asserts that non-competes are state law issues, necessitating a reasonableness standard based on duration, geographic scope, and specific industry limitations.

Impact on Med Spas

Most med spas utilize non-compete agreements to retain providers and protect business interests. Courtney explains that while non-competes are enforceable if reasonable, overly restrictive clauses (e.g., prohibiting practice in the same field indefinitely) are not permissible ([44:55]). Med spas must now reassess their employment contracts to align with state-specific regulations and ensure enforceability ([40:46]).

Restrictive Covenants Best Practices

Courtney advises med spa owners to implement restrictive covenants that are time-bound (e.g., one year), geographically limited (e.g., 50-mile radius), and specific to the practice area ([44:50]). Additionally, she underscores the importance of non-solicitation clauses to protect business interests post-employment.

Compliance in Med Spas

Physician Oversight and Scope of Practice

A significant portion of the discussion ([19:44]–[25:13]) revolves around the necessity of proper physician oversight in med spa operations. Courtney warns against improper delegation and the importance of aligning tasks with the appropriate license holders. She cites recent crackdowns, such as in Texas and Illinois, where lack of compliant oversight led to severe legal repercussions for med spas ([23:20], [24:28]).

Internal Audits and Policies

To mitigate risks, Courtney recommends that med spa owners conduct thorough internal audits of their staff licenses, define clear scopes of practice, and establish robust policies and procedures. Regular consultations with medical directors and ensuring their active involvement in practice operations are crucial steps ([27:02]).

Contractual Pitfalls in Med Spas

Courtney highlights common contractual issues such as auto-renewal clauses, choice of law, and venue provisions which can pose significant risks if not properly negotiated ([32:54]). She advises med spa owners to scrutinize vendor contracts, avoid unfavorable terms, and ensure compliance with lease agreements concerning permitted use of premises.

AI Applications in Compliance

Leveraging AI for Legal Efficiency

Courtney shares her innovative approach to integrating AI into compliance workflows. She discusses the development of AI bots, like "Lisa," which assist in reviewing contracts and identifying high-risk clauses by flagging pertinent sections and summarizing key points ([47:04]). This automation allows for more efficient legal management without incurring high attorney fees.

AI in Strategic Business Planning

Beyond compliance, Courtney utilizes AI for business strategy, such as revenue goal planning. Her AI-driven tools analyze service offerings and provide actionable insights to help med spa owners achieve financial targets ([51:32]). These applications demonstrate the potential of AI to enhance both legal compliance and business operations within the med spa industry.

Action Items for Med Spa Owners

1. Review and Update Malpractice Insurance:

   • Ensure that prescribing GLP-1s is covered and consult with insurance brokers for clarity ([06:17]–[06:26]).

2. Revise Employment Contracts:

   • Implement reasonable non-compete and non-solicitation clauses tailored to state laws ([40:46]–[46:36]).

3. Enhance Physician Oversight:

   • Conduct regular audits of staff licenses and define clear scopes of practice ([19:44]–[25:07]).

4. Negotiate Vendor Contracts:

   • Avoid unfavorable terms such as auto-renewal clauses and restrictive venue provisions ([32:54]).

5. Implement AI Tools:

   • Utilize AI bots for contract review and business planning to streamline compliance and operational efficiency ([47:04]–[54:37]).

6. Document Medical Justifications:

   • Maintain thorough documentation to support the use of compounded medications ([10:50]–[11:02]).

Conclusion

The episode provides a comprehensive analysis of the evolving legal landscape affecting med spas, particularly concerning GLP-1 medications and non-compete clauses. Courtney Walker offers actionable insights and practical solutions to help med spa owners navigate these complexities, emphasizing the importance of compliance, strategic planning, and leveraging technology. Her expertise equips listeners with the knowledge to safeguard their practices against legal pitfalls while fostering growth and operational excellence.

Notable Quotes:

• Courtney Walker ([01:03]): “The FDA removes the ability for a compounding pharmacy to create the medication until the patent expires.”

• Courtney Walker ([06:26]): “You have to make sure that everything that you're doing is covered by your malpractice.”

• Courtney Walker ([40:46]): “Non-competes have to have some level of reasonableness, like one year, 50 miles, patient practice.”

• Courtney Walker ([51:32]): “AI bots can really help fine-tune your revenue goals and offer strategic insights without replacing a CFO.”

Connect with Courtney Walker:

• Instagram: @courtapprovedaesthetics
• Website: courtapprovedaesthetics.com

This summary is intended for informational purposes and does not constitute legal advice. For personalized guidance, consult with a qualified attorney.